Concepedia

Lulu Sheng

LS

Statistics

Publications

13

Citations

508

H-Index

12

Active since

2009

Affiliations

Shanghai Sixth People's Hospital(Current)

Shanghai Jiao Tong University

Chongqing Medical University

Chongqing Public Health Medical Center

Fudan University

Lulu Sheng is an author at Shanghai Sixth People's Hospital specializing in oncology, molecular oncology, and tumor progression.

ORCID

Publications per year

2009–2023

13

Publications

13

Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA

Bai‐Quan Qiu, Xiahui Lin, Xudong Ye et al. · Aging · 2020 · 95 citations · Full text

, , +17

Doxorubicin-loaded mesoporous silica nanoparticle composite nanofibers for long-term adjustments of tumor apoptosis

Ziming Yuan, Yue Pan, Ruoyu Cheng et al. · Nanotechnology · 2016 · 82 citations

, , +17

miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression

Pengfei Zhang, Lulu Sheng, Ge Wang et al. · Oncotarget · 2016 · 67 citations · Full text

, , +17

miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2

Lulu Sheng, Ping He, Xiaomei Yang et al. · Cell Death and Disease · 2015 · 66 citations · Full text

, , +16

Circ-PTPDC1 promotes the Progression of Gastric Cancer through Sponging Mir-139-3p by Regulating ELK1 and Functions as a Prognostic Biomarker

Zhouxiao Li, Ye Cheng, Kai Fu et al. · International Journal of Biological Sciences · 2021 · 41 citations · Full text

, , +17

1–5 of 13